Can You Test Positive for Multiple Anti-ARS Antibodies?
At a Glance
Testing positive for multiple antisynthetase antibodies is possible but very uncommon. A weak double-positive commercial test may be a false result, so clinicians often confirm it with specialist testing and interpret it alongside symptoms and imaging before making a diagnosis.
Testing positive for multiple antisynthetase (anti-ARS) antibodies—such as having both anti-Jo-1 and anti-PL-12 on your lab report—is very uncommon. While it is technically possible, a “double positive” on standard commercial blood tests often warrants confirmation. In many cases, an unexpected second positive result, particularly if the test’s signal is weak, may be a testing artifact rather than a sign of multiple antibodies.
Why Do Tests Show “Double Positives”?
Many standard laboratories use a commercial blood test called a line blot (or line immunoassay). This test checks for many different antibodies at the same time by looking for reactions on a test strip. These tests are convenient, but they can sometimes cross-react or flag an antibody that isn’t really there [1]. This is especially common if the test only detected a weak signal strength (meaning the chemical reaction on the test strip was faint) [2].
In large medical studies, finding multiple myositis-specific antibodies (the broad family of antibodies that includes anti-ARS, linked to inflammatory muscle diseases) is rare. For example, in one European study of over 1,600 patients with inflammatory myopathy, researchers used a highly specialized testing method and found that only 0.2% of patients had more than one myositis-specific antibody [3]. Because of this, medical experts generally consider antisynthetase antibodies to be mutually exclusive, meaning a patient will usually only have one type [3].
When researchers looked at a different group of patients whose blood showed multiple antibodies on a standard line blot, those extra results were not confirmed when re-tested using a different, specialist method called immunoprecipitation [4].
(Note: Your test might also show a positive for an antibody like anti-Ro52. This is a myositis-associated antibody, which frequently occurs alongside anti-ARS antibodies. This is a common finding and is very different from having two distinct anti-ARS antibodies [5].)
What Happens Next?
If your lab report lists two or more antisynthetase antibodies, your doctor may want to verify the results before finalizing your diagnosis [6]. An antibody result alone does not diagnose antisynthetase syndrome, determine your disease severity, or dictate your treatment.
To figure out what is really going on, your care team may:
- Check the signal strength: Doctors will look at whether the positive results were marked as “weak” or “strong” on the lab report. Cutoffs differ between labs, but low-positive (weak) results are generally less reliable, particularly when they conflict with your actual symptoms [7][8].
- Order a confirmation test: Your doctor might send your blood to a reference laboratory (a specialty lab) for advanced testing. Depending on the antibody, they may use RNA immunoprecipitation (a specialized technique that isolates specific genetic and protein material to confirm antibodies) [6][7]. While no test is perfect, these specialist methods are often better at telling apart true antibodies from testing artifacts.
- Look at the big picture: Your doctor will compare your lab results to your physical symptoms. Because line blots can sometimes be misleading, experts recommend diagnosing the condition based on a combination of your symptoms, imaging (like X-rays or CT scans), and confirmed lab work [9].
Important Safety Note: Antisynthetase syndrome can cause serious complications, including interstitial lung disease (lung scarring). Never delay medical care while waiting for antibody confirmation. If you experience new or worsening shortness of breath, persistent cough, low oxygen readings, trouble swallowing, or marked muscle weakness, contact your clinical team promptly.
Common questions in this guide
Can a person really test positive for more than one antisynthetase antibody?
Why would a commercial line blot report two antisynthetase antibodies?
What does an anti-Ro52 result mean alongside an antisynthetase antibody?
How do doctors check whether a double-positive result is real?
Does a positive antisynthetase antibody prove I have antisynthetase syndrome?
When should I seek care while my antibody results are being confirmed?
One line in your results can change your plan.
A second anti-ARS antibody result, especially a weak one, can call for confirmation testing before a diagnosis is finalized. We check your results against the latest research to help you prepare for what’s next.
Related questions
Show more
Get notified when new evidence is published on Antisynthetase syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (9)
- 1
Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies.
Hamaguchi Y, Kuwana M, Takehara K
Clinical rheumatology 2020; (39(11)):3489-3497 doi:10.1007/s10067-020-04973-0.
PMID: 32385758 - 2
Laboratory testing for anti-synthetase antibodies: a novel algorithm to improve diagnostic accuracy.
Baucells A, Martínez-Martínez L, Fonolleda M, et al.
Clinica chimica acta; international journal of clinical chemistry 2026; (590()):121076 doi:10.1016/j.cca.2026.121076.
PMID: 42142695 - 3
Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
Betteridge Z, Tansley S, Shaddick G, et al.
Journal of autoimmunity 2019; (101()):48-55 doi:10.1016/j.jaut.2019.04.001.
PMID: 30992170 - 4
Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical Diagnoses.
Angeli F, Pedretti E, Garrafa E, et al.
Diagnostics (Basel, Switzerland) 2024; (14(19)) doi:10.3390/diagnostics14192192.
PMID: 39410596 - 5
A multivariable probability score integrating routine immunoassay results for the immunological assessment of antisynthetase syndrome.
Luchoro JF, Torradeflot M, Domènech C, et al.
Frontiers in immunology 2026; (17()):1832694 doi:10.3389/fimmu.2026.1832694.
PMID: 42292391 - 6
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank.
Loganathan A, Zanframundo G, Yoshida A, et al.
Clinical and experimental rheumatology 2024; (42(2)):277-287 doi:10.55563/clinexprheumatol/s14zq8.
PMID: 38488094 - 7
A Comparison of Line Blots, Enzyme-linked Immunosorbent, and RNA-immunoprecipitation Assays of Antisynthetase Antibodies in Serum Samples from 44 Patients.
Shinoda K, Okumura M, Yamaguchi S, et al.
Internal medicine (Tokyo, Japan) 2022; (61(3)):313-322 doi:10.2169/internalmedicine.7824-21.
PMID: 35110513 - 8
Improved Detection of Myositis-Specific Autoantibodies Using Luciferase Immunoprecipitation Systems Assay: Comparison With Line Blot and Conventional Immunoprecipitation.
Burbelo PD, Pinal-Fernandez I, Casal-Dominguez M, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2026; (78(9)):1952-1960 doi:10.1002/art.70103.
PMID: 41728979 - 9
Signal or noise? Apply myositis autoantibody line-blot immunoassays in real-world settings: implications for diagnostic accuracy.
Lai PH, Cheng CF, Lee TJ, et al.
Clinical rheumatology 2026; (45(2)):1141-1153 doi:10.1007/s10067-025-07904-z.
PMID: 41553408
This page is for informational purposes only and does not constitute medical advice. A qualified clinician should interpret your antisynthetase antibody results alongside your symptoms and other tests.